United States · FDA National Drug Code directory
Benzonatate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51224-010_8c55a83f-07f4-4f96-8b85-b1df90c8e116
- Product NDC
- 51224-010
- Form
- CAPSULE
- Composition / generic term
- Benzonatate
- Labeler
- TAGI Pharma, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170907
- Source listing expiry
- 20261231
Source-listed ingredients
- BENZONATATE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (51224-010-50) · 51224-010-50
- 500 CAPSULE in 1 BOTTLE (51224-010-60) · 51224-010-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →